Hi and welcome as a potential CU6 shareholder. I am happy to hold this long term now it has tested the highs and come back to value pre the data results and multiple phase 3 end points pre FDA approvals and revenues/profits......
The next 2 years should be action packed and once revenue is rolling in any buyout and it will happen the longer down the road the bigger the value. TLX i agree is a cookie cutter we must follow but with far superior products that fantastic revenue growth they are getting is a super exciting prospect for CU6. Lots of water to go under the bridge but technically we needed to drop back to around $3.90 and that we have done. I'm long more than ever and comfortable with cash on hand and result runway due to drop this year to guide the share price.
I've taken a good swing at GLN for a trade and if that works out will have a 3rd dip here on CU6 as i feel it's potential is very good. My average is now $3.82 so i'm stoked after initially watching for ages and buying in at $2.75 last March and selling in the September highs.
Plenty of faithful here and one would assume more funds will also take the opportunity to add or top up now it's in the ASX200, my gut said it would tank on ASX200 inclusion like many fast risers prior and it did. But the data results on small samples are too good to ignore if they replicate them on a larger scale the MKT cap is limitless
CU6 Price at posting:
$3.89 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)